The Asian-Pacific (APAC) region is one of the fastest growing areas for clinical trials. There are many benefits to conducting trials in the region, including low cost, ease of regulatory compliance, a growing patient population, and the presence of top clinical institutions. The APAC CRO market was valued at $7.6 billion in 2021 and is forecasted to reach $12 billion by 2025.
Still, there are challenges that drug developers must be aware of if planning to conduct studies in the APAC region. Those challenges include the lingering impact of COVID, geopolitics, and regulatory idiosyncrasies.
Check out this On-Demand webinar from Clinical Leader Live featuring experts covering all aspects of trial conduct in this growing clinical hot spot.